Literature DB >> 2060340

Maximal sniff mouth pressure compared with maximal inspiratory pressure in acute respiratory failure.

F Héritier1, C Perret, J W Fitting.   

Abstract

Inspiratory muscle strength most often is better reflected by sniff Pes than PImax against occlusion. Furthermore, sniff Pes can be estimated noninvasively by the measurement of sniff Pmo in normal subjects and in patients with respiratory muscle weakness. The aim of this study was to compare sniff Pmo and P.PImax to assess inspiratory muscle strength in patients with acute respiratory failure. The highest pressure was produced by P.PImax in 61 percent of measurements, and by sniff Pmo in 39 percent. Above 35 cm H2O P.PImax yielded the highest pressure in 55 percent of cases and the ratio sniff Pmo/P.PImax was 1.20 +/- 0.54. Below 35 cm H2O, P.PImax yielded the highest pressure in 75 percent of cases and the ratio sniff Pmo/P.PImax was 0.76 +/- 0.35 (p less than 0.02). Thus, measurements of sniff Pmo and P.PImax complement one another for assessing inspiratory muscle strength. However, sniff Pmo underestimates inspiratory muscle strength in patients with severe inspiratory muscle weakness.

Entities:  

Mesh:

Year:  1991        PMID: 2060340     DOI: 10.1378/chest.100.1.175

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

Review 1.  Respiratory aspects of neurological disease.

Authors:  M I Polkey; R A Lyall; J Moxham; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

2.  Limitations of sniff nasal pressure in patients with severe neuromuscular weakness.

Authors:  N Hart; M I Polkey; T Sharshar; L Falaize; B Fauroux; J C Raphaël; F Lofaso
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

3.  Clinical predictive value of manual muscle strength testing during critical illness: an observational cohort study.

Authors:  Bronwen A Connolly; Gareth D Jones; Alexandra A Curtis; Patrick B Murphy; Abdel Douiri; Nicholas S Hopkinson; Michael I Polkey; John Moxham; Nicholas Hart
Journal:  Crit Care       Date:  2013-10-10       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.